Evaluation of the in vivo disintegration of solid dosage forms of a bile acid sequestrant in dogs using γ-scintigraphy and correlation to in vitro disintegration

Pharmaceutical Research

Volumn 20, Issue 3, 2003, Pages 460-464

  Hussain, Munir A ^a   Chang, Rong Kun ^b   Sandefer, Erik ^c,d   Page, Richard C ^c,d   Digenis, George A ^c  

^a BRISTOL MYERS SQUIBB   (United States)

^b Shire Laboratories Inc   (United States)

^c University of Kentucky   (United States)

^d Scintipharma Inc   (United States)

Author keywords

Bile acid sequestrant; DMP 504; In vitro disintegration; In vivo disintegration; Tablets; scintigraphy

Indexed keywords

BILE ACID; DMP 504;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOG; FEMALE; GAMMA SCINTIGRAPHY; IN VITRO STUDY; IN VIVO STUDY; NEUTRON; NONHUMAN; PRIORITY JOURNAL; RADIOACTIVITY; TABLET;

EID: 0037336672     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022620624586     Document Type: Article

References (12)

1. S. M. Grundy, E. H. Ahrens, Jr., and G. Salen. Interruption of the enterohepatic circulation of bile acids in man: comparative effects of cholestyramine and ileal exclusion on cholesterol metabolism. J. Lab. Clin. Med. 78:94-121 (1997).
2. G. D. Figuly. New Crosslinked Polymeric Ammonium Salts Used as Bile-Acid Sequestrants, Absorbants or as Charge Transfer Agents, E.I. DuPont De Nemours and Co., WO Patent 9404596-A1, 1994.
3. S. D. Royce, G. D. Figuly, and J. R. Matos. Crosslinked polymeric Ammonium Salts. The DuPont Merck Pharmaceutical Company, U.S. Patent 5,556,619 (1996).
4. K. S. Raghavan, R-K. Chang, J. Pang, G. D. Figuly, and M. A. Hussain. Physical and chemical properties of DMP 504, a polyalkylammonium-based bile acid sequestrant. Pharm. Dev. Technol. 2:233-241 (1997).
5. L.-S. Wu, T. J. McCormick, R.-K. Chang, J. Pang T. McCummings, M. Ramos, and M. A. Hussain. Development of an unconventional in-vitro drug release test method for a bile acid sequestrant, DMP 504, tablet. Pharm. Res. 16:1136-1139 (1999).
6. M. A. Schreiber, K. L. Moyer, B. J. Mueller, M. A. Ramos, J. S. Green, L. White, W. Hedgepeth, K. Juliano, J. R. Scull, and P. K. Hovsepian. Development and validation of cholate binding capacity method for DMP 504, a bile acid sequestrant. J. Pharm. Biomed. Anal. 25:87-92 (2001).
7. J. T. Fell and G. Digenis. Imaging and behaviour of solid oral dosage forms in vivo. Int. J. Pharm. 22:1-15 (1984).
8. L. C. Kaus, J. T. Fell, H. Sharma, and D. C. Taylor. On the intestinal transit of a single non-disintegrating object. Int. J. Pharm. 20:315-323 (1984).
9. A. Parr, M. Jay, G. A. Digenis, and R. M. Beihn. Radiolabeling of intact tablets by neutron activation for in vivo scintigraphic studies. J. Pharm. Sci. 74:590-591 (1985).
10. A. Parr and M. Jay. Radiolabeling of intact dosage forms by neutron activation: effect on in vitro performance. Pharm. Res. 4:524-526 (1987).
11. R.-K. Chang, K. S. Raghavan, and M. A. Hussain. A study on gelatin capsule brittleness: Moisture transfer between the capsule shell and its content. J. Pharm. Sci. 87:556-558 (1998).
12. R.-K. Chang, M. Shinwari, M. Leonzio, L-S Wu, J. Pang, and M. A. Hussain. Evaluation of the disintegrant properties for an experimental, crosslinked polyalkylammonium polymer. Int. J. Pharm. 173:87-92 (1998).